Literature DB >> 5101137

Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans.

T P Monath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5101137     DOI： 10.1093/oxfordjournals.aje.a121232

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  20 in total

1.  Yellow fever vaccine seroconversion in travelers.

Authors:  Allison Kay; Lin H Chen; Maggie Sisti; Thomas P Monath
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

2.  Characterization of defective viral RNA produced during persistent infection of Vero cells with Murray Valley encephalitis virus.

Authors:  M U Lancaster; S I Hodgetts; J S Mackenzie; N Urosevic
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 3.  Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

Authors:  Huabin Liang; Min Lee; Xia Jin
Journal:  Cell Mol Immunol       Date:  2015-10-05       Impact factor: 11.530

4.  Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Authors:  Harry E Prince; Leslie H Tobler; Mary Lapé-Nixon; Gregory A Foster; Susan L Stramer; Michael P Busch
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 5.  The dengue viruses.

Authors:  E A Henchal; J R Putnak
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

6.  Humoral immunity against Francisella tularensis after natural infection.

Authors:  P Koskela; A Salminen
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Enzyme-linked immunosorbent assay (ELISA) for detection of specific IgA antibodies to mumps virus.

Authors:  B Halevy; I Sarov
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

8.  Persistence of immunoglobulin G and immunoglobulin M antibodies after postnatal rubella infection determined by solid-phase radioimmunoassay.

Authors:  O H Meurman
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

9.  Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis.

Authors:  Robert B Tesh; Amelia P A Travassos da Rosa; Hilda Guzman; Tais P Araujo; Shu-Yuan Xiao
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Cell-mediated and humoral immunity induced by a live Francisella tularensis vaccine.

Authors:  P Koskela; E Herva
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.